Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance

T 细胞稳态和耐受性中的转化生长因子 β

基本信息

  • 批准号:
    7023314
  • 负责人:
  • 金额:
    $ 38.37万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-03-15 至 2007-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary: T-cell homeostasis is an essential process for maintaining peripheral lymphocyte pool size. T cells must provide a diverse repertoire of antigen recognition to effectively recognize and destroy pathogens that they encounter. Antigen-specific T-cell pools are expanded during viral infection and are contracted after the initial viral clearance to make space for the entire T-cell repertoire. This is a tightly regulated process since the space available for lymphocytes is limited. Transforming Growth Factor ? signaling is required to prevent autoimmune disease and dysregulation of T-cell homeostasis. Normally, T cells must interact with self-MHC molecules for their survival, maintenance and homeostatic expansion, but under some pathological conditions such interactions cause inappropriate activation of T cells leading to autoimmune disease. Characterization of TGF??-deficient mice has revealed that their autoimmune disease results from spontaneous activation of their T cells in response to self-antigen recognition by having an inappropriately low threshold level of activation through a Calcium-Calcineurin signaling cascade. Elimination of T cells or their self-antigen recognition is sufficient to prevent autoimmune disease in these mice, and reducing calcineurin signaling drastically attenuates their autoimmune disease. In addition, it is known that without TGF? signaling there are less T-regulatory cells, the cells that mediate immune tolerance. Here we propose to investigate mechanisms and processes underlying the role of TGF? in the regulation of T-cell homeostasis and self-tolerance. Firstly, we will address how TGF?1 regulates T-cell pool size using an Ovalbumin-specific T-cell receptor transgenic TGF?1-deficient mouse strain. Adoptive transfer and Ovalbumin activation studies will be used. Secondly, we will study the role of TGF?? and its signaling pathways in peripheral T-cell regulation. T-regulatory cell transfer to effect tolerizing activity will be performed and the passive or infectious nature of that activity will be determined. Relevance: Dysregulation of homeostatic process has been implicated in many human diseases such as AIDS, leukemia, inflammatory bowl disease, and autoimmune diseases such as type 1 diabetes, multiple sclerosis and arthritis. Processes involved in T-cell homeostasis such as lymphocyte activation, survival and death are presently under intensive study because of their relevance to these diseases. The information gained from these studies will be useful for developing therapies for the induction of tolerance during transplantation, for enhancing tumor vaccine potential, and for the prevention of autoimmune disease.
描述(由申请人提供):项目摘要:T细胞动态平衡是维持外周淋巴细胞池大小的基本过程。T细胞必须提供不同的抗原识别能力,才能有效地识别和摧毁它们遇到的病原体。抗原特异性T细胞库在病毒感染期间扩大,并在病毒最初清除后收缩,为整个T细胞库腾出空间。这是一个严格控制的过程,因为可供淋巴细胞使用的空间是有限的。转化生长因子?信号是预防自身免疫性疾病和T细胞稳态失调所必需的。正常情况下,T细胞必须与自身MHC分子相互作用才能生存、维持和自我平衡扩张,但在某些病理条件下,这种相互作用会导致T细胞的不适当激活,从而导致自身免疫性疾病。转化生长因子β基因缺陷小鼠的特征表明,他们的自身免疫性疾病是由于T细胞自发激活,以响应自身抗原识别,通过钙-钙调神经磷酸酶信号级联反应具有不适当的低阈值激活水平。消除T细胞或其自身抗原识别足以预防这些小鼠的自身免疫性疾病,减少钙调神经磷酸酶信号可显著减轻它们的自身免疫性疾病。另外,据了解,没有转化生长因子?信号表明,T调节细胞较少,这种细胞介导免疫耐受。在这里,我们建议研究潜在的机制和过程中的转化生长因子?在调节T细胞的动态平衡和自我耐受方面。首先,我们将使用卵蛋白特异性T细胞受体转基因转化生长因子1缺陷小鼠品系来说明转化生长因子1如何调节T细胞池的大小。将使用过继转移和卵清蛋白激活研究。其次,我们将研究转化生长因子的作用??及其在外周T细胞调节中的信号通路。将进行T-调节性细胞转移以影响耐受活动,并将确定该活动的被动或感染性。相关性:体内平衡过程的失调与许多人类疾病有关,如艾滋病、白血病、炎症性肠病,以及自身免疫性疾病,如1型糖尿病、多发性硬化症和关节炎。参与T细胞稳态的过程,如淋巴细胞的激活、存活和死亡,目前正在深入研究,因为它们与这些疾病有关。从这些研究中获得的信息将有助于开发诱导移植耐受的治疗方法,增强肿瘤疫苗的潜力,以及预防自身免疫性疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS DOETSCHMAN其他文献

THOMAS DOETSCHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS DOETSCHMAN', 18)}}的其他基金

Cell-specific analysis of transcription and epigenomic status in PDAC
PDAC 转录和表观基因组状态的细胞特异性分析
  • 批准号:
    8468670
  • 财政年份:
    2012
  • 资助金额:
    $ 38.37万
  • 项目类别:
Cell-specific analysis of transcription and epigenomic status in PDAC
PDAC 转录和表观基因组状态的细胞特异性分析
  • 批准号:
    8227178
  • 财政年份:
    2012
  • 资助金额:
    $ 38.37万
  • 项目类别:
Experimental Mice
实验小鼠
  • 批准号:
    7944527
  • 财政年份:
    2009
  • 资助金额:
    $ 38.37万
  • 项目类别:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
T 细胞稳态和耐受性中的转化生长因子 β
  • 批准号:
    7197991
  • 财政年份:
    2006
  • 资助金额:
    $ 38.37万
  • 项目类别:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
T 细胞稳态和耐受性中的转化生长因子 β
  • 批准号:
    7492844
  • 财政年份:
    2006
  • 资助金额:
    $ 38.37万
  • 项目类别:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
T 细胞稳态和耐受性中的转化生长因子 β
  • 批准号:
    7759458
  • 财政年份:
    2006
  • 资助金额:
    $ 38.37万
  • 项目类别:
Transforming Growth Factor beta in T-Cell Homeostasis and Tolerance
T 细胞稳态和耐受性中的转化生长因子 β
  • 批准号:
    7775091
  • 财政年份:
    2006
  • 资助金额:
    $ 38.37万
  • 项目类别:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
FGF2 和 TGFbeta 在心脏肥大中的作用
  • 批准号:
    6623478
  • 财政年份:
    2002
  • 资助金额:
    $ 38.37万
  • 项目类别:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
FGF2 和 TGFbeta 在心脏肥大中的作用
  • 批准号:
    6729931
  • 财政年份:
    2002
  • 资助金额:
    $ 38.37万
  • 项目类别:
Roles of FGF2 and TGFbeta in cardiac hypertrophy
FGF2 和 TGFbeta 在心脏肥大中的作用
  • 批准号:
    6466184
  • 财政年份:
    2002
  • 资助金额:
    $ 38.37万
  • 项目类别:

相似海外基金

Significance of transforming growth factors for ocular malignant tumors and their application in gene therapy.
转化生长因子对眼部恶性肿瘤的意义及其在基因治疗中的应用。
  • 批准号:
    15591873
  • 财政年份:
    2003
  • 资助金额:
    $ 38.37万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
ROLE OF TRANSFORMING GROWTH FACTORS IN THE INTESTINE
转化生长因子在肠道中的作用
  • 批准号:
    3080759
  • 财政年份:
    1989
  • 资助金额:
    $ 38.37万
  • 项目类别:
ROLE OF TRANSFORMING GROWTH FACTORS IN THE INTESTINE
转化生长因子在肠道中的作用
  • 批准号:
    3080757
  • 财政年份:
    1989
  • 资助金额:
    $ 38.37万
  • 项目类别:
ROLE OF TRANSFORMING GROWTH FACTORS IN THE INTESTINE
转化生长因子在肠道中的作用
  • 批准号:
    3080755
  • 财政年份:
    1989
  • 资助金额:
    $ 38.37万
  • 项目类别:
ROLE OF TRANSFORMING GROWTH FACTORS IN THE INTESTINE
转化生长因子在肠道中的作用
  • 批准号:
    3080758
  • 财政年份:
    1989
  • 资助金额:
    $ 38.37万
  • 项目类别:
ROLE OF TRANSFORMING GROWTH FACTORS IN THE INTESTINE
转化生长因子在肠道中的作用
  • 批准号:
    3080756
  • 财政年份:
    1989
  • 资助金额:
    $ 38.37万
  • 项目类别:
TRANSFORMING GROWTH FACTORS IN COLONIC NEOPLASIA
结肠肿瘤中的转化生长因子
  • 批准号:
    3189666
  • 财政年份:
    1988
  • 资助金额:
    $ 38.37万
  • 项目类别:
TRANSFORMING GROWTH FACTORS IN COLONIC NEOPLASIA
结肠肿瘤中的转化生长因子
  • 批准号:
    3189669
  • 财政年份:
    1988
  • 资助金额:
    $ 38.37万
  • 项目类别:
TRANSFORMING GROWTH FACTORS IN COLONIC NEOPLASIA
结肠肿瘤中的转化生长因子
  • 批准号:
    3189668
  • 财政年份:
    1988
  • 资助金额:
    $ 38.37万
  • 项目类别:
REGULATION OF TRANSFORMING GROWTH FACTORS
转化生长因子的调节
  • 批准号:
    3186142
  • 财政年份:
    1987
  • 资助金额:
    $ 38.37万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了